Cargando…

Rationale for targeting complement in COVID‐19

A novel coronavirus, SARS‐CoV‐2, has recently emerged in China and spread internationally, posing a health emergency to the global community. COVID‐19 caused by SARS‐CoV‐2 is associated with an acute respiratory illness that varies from mild to the life‐threatening acute respiratory distress syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polycarpou, Anastasia, Howard, Mark, Farrar, Conrad A, Greenlaw, Roseanna, Fanelli, Giorgia, Wallis, Russell, Klavinskis, Linda S, Sacks, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323084/ https://www.ncbi.nlm.nih.gov/pubmed/32559343 http://dx.doi.org/10.15252/emmm.202012642

Ejemplares similares

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?
por: Polycarpou, Anastasia, et al.
Publicado: (2021)

Collectin-11 (CL-11) Is a Major Sentinel at Epithelial Surfaces and Key Pattern Recognition Molecule in Complement-Mediated Ischaemic Injury
por: Nauser, Christopher L., et al.
Publicado: (2018)

Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2021)

Correction to: Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2022)

l‐Fucose prevention of renal ischaemia/reperfusion injury in Mice
por: Howard, Mark C., et al.
Publicado: (2019)

Which pathways trigger the role of complement in ischaemia/reperfusion injury?
por: Farrar, Conrad A., et al.
Publicado: (2012)

Human stem cell-derived retinal epithelial cells activate complement via collectin 11 in response to stress
por: Fanelli, Giorgia, et al.
Publicado: (2017)

FRA2 Is a STAT5 Target Gene Regulated by IL-2 in Human CD4 T Cells
por: Rani, Aradhana, et al.
Publicado: (2014)

Structural and functional diversity of collectins and ficolins and their relationship to disease
por: Howard, Mark, et al.
Publicado: (2017)

A timely update of global COVID-19 vaccine development
por: Klavinskis, Linda S., et al.
Publicado: (2020)

A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
por: Kassimatis, Theodoros, et al.
Publicado: (2017)

Effects of multiple-dose ponesimod, a selective S1P(1) receptor modulator, on lymphocyte subsets in healthy humans
por: Jurcevic, Stipo, et al.
Publicado: (2016)

Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway
por: Wallis, Russell
Publicado: (2007)

Soluble Collectin 11 (CL-11) Acts as an Immunosuppressive Molecule Potentially Used by Stem Cell-Derived Retinal Epithelial Cells to Modulate T Cell Response
por: Fanelli, Giorgia, et al.
Publicado: (2023)

The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis
por: Choudhry, Naheed, et al.
Publicado: (2016)

Targeting complement activation in COVID-19
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2020)

Complement as a target in COVID-19?
por: Risitano, Antonio M., et al.
Publicado: (2020)

Carbohydrate recognition and complement activation by rat ficolin-B
por: Girija, Umakhanth Venkatraman, et al.
Publicado: (2011)

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
por: Rizk, Dana V., et al.
Publicado: (2023)

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020)

Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2
por: Krarup, Anders, et al.
Publicado: (2007)

Targeting complement cascade: an alternative strategy for COVID-19
por: Ram Kumar Pandian, Sureshbabu, et al.
Publicado: (2020)

Author Correction: Complement as a target in COVID-19?
por: Risitano, Antonio M., et al.
Publicado: (2020)

Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease
por: Ng, Nicole, et al.
Publicado: (2021)

The Human Intestinal IgA Response; Burning Questions
por: Spencer, Jo, et al.
Publicado: (2012)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Tackling COVID‐19 infection through complement‐targeted immunotherapy
por: Jodele, Sonata, et al.
Publicado: (2020)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
por: Barkoff, Courtney M., et al.
Publicado: (2020)

The workplace and psychosocial experiences of Australian junior doctors during the COVID‐19 pandemic
por: Hunter, Roseanna, et al.
Publicado: (2022)

Engineering Novel Complement Activity into a Pulmonary Surfactant Protein
por: Venkatraman Girija, Umakhanth, et al.
Publicado: (2010)

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
por: Kleanthous, Harry, et al.
Publicado: (2021)

Fucose as a new therapeutic target in renal transplantation
por: Howard, Mark C, et al.
Publicado: (2020)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Near-planar Solution Structures of Mannose-binding Lectin Oligomers Provide Insight on Activation of Lectin Pathway of Complement
por: Miller, Ami, et al.
Publicado: (2012)

Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways
por: Benlahrech, Adel, et al.
Publicado: (2009)

Optimal intervention strategies to mitigate the COVID-19 pandemic effects
por: Kasis, Andreas, et al.
Publicado: (2022)

The Rationale for Potential Pharmacotherapy of COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2020)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

Complement activation in patients with COVID-19: A novel therapeutic target
por: Cugno, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mupodrq0bhn6naldhpapr4v5a